Skip to main content

Syndicate contentWORCESTER

WPI researchers take aim at hard-to-treat fungal infections

WORCESTER, Mass. -- A team of researchers at the Worcester Polytechnic Institute (WPI) Life Sciences and Bioengineering Center at Gateway Park has developed a new model system to study fungal infections.

Newly revised guidelines for managing thyroid cancer published in Thyroid journal

New Rochelle, NY, November 5, 2009 -- The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid c

Migrating monarch butterflies 'nose' their way to Mexico

WORCESTER, Mass. -- The annual migration of monarch butterflies from across eastern North America to a specific grove of fir trees in Mexico has long fascinated scientists who have sought to understand just how these delicate creatures can navigate up to 2,000 miles to a single location.

Online social networks leak personal information to tracking sites, new study shows

WORCESTER, Mass. -- More than a half billion people use online social networks, posting vast amounts of information about themselves to share with online friends and colleagues.

Reprogramming human cells without inserting genes

WORCESTER, Mass. -- A research team comprised of faculty at Worcester Polytechnic Institute's (WPI) Life Sciences and Bioengineering Center (LSBC) and investigators at CellThera, a private company also located at the LSBC, has discovered a novel way to turn on stem cell genes in human fibroblasts (skin cells) without the risks associated with inserting extra genes or using viruses.

ISU researchers find possible treatment for spinal muscular atrophy

AMES, Iowa - Spinal Muscular Atrophy is the second-leading cause of infant mortality in the world.

Ravindra Singh, associate professor in biomedical sciences at Iowa State University's College of Veterinary Medicine, would like to see Spinal Muscular Atrophy lose its high ranking and even slide off the list altogether.

DNA template could explain evolutionary shifts

HOUSTON -- (June 21, 2009) -- Rearrangements of all sizes in genomes, genes and exons can result from a glitch in DNA copying that occurs when the process stalls at a critical point and then shifts to a different genetic template, duplicating and even triplicating genes or just shuffling or deleting part of the code within them, said researchers from Baylor College of Medicine in a recent rep

A lethal cancer knocked down by one-two drug punch

Bar Harbor, Maine -- In the battle against cancer, allies can come from unexpected sources. Research at The Jackson Laboratory has yielded a new approach to treating leukemia, one that targets leukemia-proliferating cells with drugs that are already on the market.

First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal

New Rochelle, NY, May 27, 2009?New guidelines designed to standardize and optimize the diagnosis, treatment, and monitoring of patients with Medullary Thyroid Carcinoma (MTC), an uncommon and challenging form of thyroid cancer, have been developed by the American Thyroid Association and published online ahead of print in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, In

UMMS researchers isolate first 'neuroprotective' gene in patients with amyotrophic lateral sclerosis

WORCESTER, Mass. -- A genetic variant that substantially improves survival of individuals with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been indentified by a consortium of researchers led by John Landers, PhD, Associate Professor of Neurology and Robert Brown, MD, DPhil, Chair and Professor of Neurology at the University of Massachusetts Medical School.

Novel antibody prevents infection by hepatitis C virus

Boston, Mass. -- Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV).

UMass medical school researchers report oral delivery system for RNAi therapeutics

WORCESTER, Mass.--Researchers at the University of Massachusetts Medical School (UMMS) report today on a novel approach to the delivery of small bits of genetic material in order to silence genes using "RNA interference"--and in the process, discovered a potent method of suppressing inflammation in mice similar to what occurs in a range of human diseases.

New therapeutic strategy could target toxic protein in most patients with Huntington's disease

Howard Hughes Medical Institute researchers have designed tiny RNA molecules that shut off the gene that causes Huntington's disease without damaging that gene's healthy counterpart, which maintains the health and vitality of neurons.

UMMS researchers publish DNA identification of czar's children

Cutting edge science has finally put to rest a 90-year-old mystery that involved nobility, revolution, murder and the long-romanticized story of a child's escape from the firing squad.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes